Stay updated on Quest Diagnostics Press Releases

Sign up to get notified when there's something new on the Quest Diagnostics Press Releases page.
Latest website image capture
Clouds background image

Latest updates to the Quest Diagnostics Press Releases page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    Quest Diagnostics has introduced a new advanced pharmacogenomics offering and reported significant findings regarding fentanyl positivity in drug tests, while also removing information about testing for the Oropouche virus and an FDA-cleared blood test for Alzheimer's disease.
    Difference
    100%
    Check dated 2025-09-06T14:47:01.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The webpage has added significant information regarding a joint venture between Corewell Health and Quest Diagnostics to enhance laboratory services in Michigan, as well as the FDA granting Breakthrough Device Designation for a new circulating tumor DNA test. However, several corporate announcements and reports from Quest Diagnostics have been removed.
    Difference
    100%
    Check dated 2025-08-30T11:33:47.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    Quest Diagnostics has announced its participation in the Baird 2025 Global Healthcare Conference and declared a quarterly cash dividend of $0.80 per share. However, the company has removed information regarding its collaboration with MD Anderson for a multi-cancer blood test.
    Difference
    100%
    Check dated 2025-08-16T04:31:32.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    Quest Diagnostics has completed the acquisition of clinical testing assets from Fresenius Medical Care and launched two clinical trials related to cancer treatment, while previous announcements regarding a cash dividend and a conference appearance have been removed.
    Difference
    27%
    Check dated 2025-08-08T23:48:00.000Z thumbnail image
  7. Check
    46 days ago
    Change Detected
    Summary
    The page now includes a significant update about Athena Diagnostics' new testing technology for ataxia movement disorders, while previous information regarding oncologists' reports on cancer recurrence has been removed.
    Difference
    16%
    Check dated 2025-08-01T19:18:20.000Z thumbnail image
  8. Check
    53 days ago
    Change Detected
    Summary
    The page has been updated to reflect the second quarter 2025 financial results for Quest Diagnostics, replacing the first quarter results.
    Difference
    16%
    Check dated 2025-07-25T14:32:25.000Z thumbnail image

Stay in the know with updates to Quest Diagnostics Press Releases

Enter your email address, and we'll notify you when there's something new on the Quest Diagnostics Press Releases page.